https://doi.org/10.4081/aiua.2025.12658
0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Survival and oncological outcomes for young men (≤ 55 years) undergoing radical prostatectomy for localized prostate cancer

Authors

Shahryar Zeighami
Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of.
Ali Ariafar
Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of.
Alireza Makarem
Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of.
Faisal Ahmed
https://orcid.org/0000-0001-7188-2715
Department of Urology, Ibb University of Medical Since, Ibb, Yemen.
Mohammadreza Askarpour
askarvip2@gmail.com
https://orcid.org/0000-0001-5702-4036
Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of.

Objectives: This research aimed to compare the prostate cancer (PCa) features, survival rate, and functional outcomes after open suprapubic Radical Prostatectomy (RP) between younger men (≤ 55 years) and older men (> 55 years).
Methods: In this retrospective cohort study, we studied 134 patients with clinically localized PCa who underwent RP at our centers between 2011 and 2019, with 26 (19.40%) patients aged ≤ 55. Pathological parameters, survival rate (at 5 and 10 years), and functional outcomes such as erectile function and continence rate (at two years from RP) were evaluated retrospectively, and the two groups were compared. The Chi-square test, Kaplan-Meier, and Cox proportional hazards method were used for statistical analysis.
Results: Men aged ≤ 55 had greater rates of organ-confined tumors, lower D'Amico risk grouping, and pathologic Gleason grade than their older counterparts (all p<0.05). The median follow-up was 81 months. The overall survival rate at five and ten years in younger men vs older counterparts was 96.15% vs. 93.47% and 92.15% v. 82.13% but was not statistically significant (p=0.1539). Five-year biochemical recurrence-free and metastasis-free survival rates in younger men vs older counterparts were 96.2% vs 81.5% and 75.7% vs 51.5%. Men > 55 years were associated with worse BCR-free and metastasis-free survival in univariate analysis and worsening BCR in multivariate analysis. The continence rate was significantly improved in men aged ≤ 55 years compared to older counterparts (OR: 5.08; 95% CI: 1.61-22.61; p=0.013). However, erectile function was not statistically significant between groups [for moderate ED: (OR:1.08; 95% CI: 0.43-2.79, p=0.865), for severe ED (OR: 1.60; 95% CI: 0.35-11.50, p=0.579=)].
Conclusions: Our study showed that survival rates were similar in younger men (≤ 55 years) and their older counterparts. However, older patients who underwent RP had more advanced disease, worse BCR-free survival, and worse continence rate. For localized prostate cancer patients under 55 years of age, radical prostatectomy is an excellent treatment option with excellent long-term survival results. Given the relatively small number of patients younger than 55, a large cohort study with long-term postprocedural follow-up is needed to validate this observation.

Dimensions

Altmetric

Article has an altmetric score of 1

PlumX Metrics

Plum Print visual indicator of research metrics
    No metrics available.
see details

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Milonas D, Venclovas Z, Gudinaviciene I, et al. Long-term oncological outcomes for young men undergoing radical prostatectomy for localized prostate cancer. Biomed Res Int 2017; 2017:9858923.
Hussein S, Satturwar S, Van der Kwast T. Young-age prostate cancer. J Clin Pathol. 2015; 68:511.
Soos G, Tsakiris I, Szanto J, et al. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur
Urol. 2005; 48:739-44.
Stamatiou K, Alevizos A, Agapitos E, Sofras F. Incidence of impalpable carcinoma of the prostate and non-malignant and pre carcinomatous lesions in Greek male population: an autopsy study. Prostate 2006; 66:1319-28.
Sakr WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993; 150:379-85.
Ariafar A, Zeighami S, Salehipour M, et al. An investigation of the pathology report of prostate cancer patients with radical prostatectomy in southern Iran: a cross-sectional study. Middle East J Cancer. 2021; 12:69-78.
Kinnear NJ, Kichenadasse G, Plagakis S, et al. Prostate cancer in men aged less than 50 years at diagnosis. World J Urol. 2016;34:1533-9.
Tjaden HB, Culp DA, Flocks RH. Clinical adenocarcinoma of the prostate in patients under 50 years of age. J Urol. 1965; 93:618-21.
Parker PM, Rice KR, Sterbis JR, et al. Prostate cancer in men less than the age of 50: a comparison of race and outcomes. Urology. 2011; 78:110-5.
Becker A, Tennstedt P, Hansen J, et al. Functional and oncological outcomes of patients aged < 50 years treated with radical prostatectomy for localized prostate cancer in a European population. BJU Int. 2014; 114:38-45.
Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974; 111:58-64.
Milonas D, Venclovas Z, Gudinaviciene I, et al. Long-Long-term oncological outcomes for young men undergoing radical prostatectomy for localized prostate cancerr. Biomed Res Int. 2017;2017:9858923.
Tan L, Wang LL, Ranasinghe W, et al. Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy. Prostate Int. 2018; 6:31-5.
Hong SK, Nam JS, Na W, et al. Younger patients have poorer biochemical outcome after radical prostatectomy in high-risk
prostate cancer. Asian J Androl. 2011; 13:719-23.
Dantanarayana ND, Hossack T, Cozzi P, et al. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia. BMC Urol. 2015; 15:124.
Freedland SJ, Presti JC, Jr., Kane CJ, et al. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004; 63:518-22.
Zheng Y, Lin SX, Wu S, et al. Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis. Cancer Med. 2020; 9:6473-84.
Lepor H. Selecting candidates for radical prostatectomy. Rev Urol. 2000; 2:182-9.
Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nat Rev Urol. 2014; 11:317-23.
Song P, Peng Z, Shu M, et al. Reduced survival of young patients under 55 years with metastatic prostate cancer: a population-based study. J Cancer. 2021; 12:4985-92.
Lu Y, Huang HH, Lau WKO. Survival outcomes of Asian younger men (< 55 years) undergoing radical prostatectomy: a review of prostate cancer database in a tertiary hospital in Singapore. Int Urol Nephrol. 2020; 52:1885-91.
Carter BS, Beaty TH, Steinberg GD, et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 1992; 89:3367-71.
Lange EM, Salinas CA, Zuhlke KA, et al. Early onset prostate cancer has a significant genetic component. Prostate. 2012;72:147-56.
Milonas D, Venclovas Z, Jievaltas M. Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer. Cent European J Urol. 2019; 72:240-6.
Ji G, Huang C, Song G, et al. Are the pathological characteristics of prostate cancer more aggressive or more indolent depending upon the patient age? Biomed Res Int. 2017; 2017:1438027.
Brajtbord JS, Punnen S, Cowan JE, et al. Age and baseline quality of life at radical prostatectomy--who has the most to lose? J Urol. 2014; 192:396-401.
Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011; 306:1205-14.
Tilki D, Maurer V, Pompe RS, et al. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age. World J Urol. 2020; 38:95-101.
Kuehhas FE, Naegele R, Eckersberger E, et al. Urinary continence after radical prostatectomy: the patient perspective. Can J
Urol. 2011; 18:5811-8. 30. Zorn KC, Wille MA, Thong AE, et al. Continued improvement of perioperative, pathological and continence outcomes during 700 robot-assisted radical prostatectomies. Can J Urol. 2009; 16:4742-9.
Theissen L, Preisser F, Wenzel M, et al. Very Very early continence after radical prostatectomy and its influencing factors. Front Surg. 2019; 6:60.
Cano Garcia C, Wenzel M, Humke C, et al. Impact of age on long-term urinary continence after robotic-assisted radical prostatectomy. . Medicina (Kaunas). 2023; 59:1153.

How to Cite

Zeighami, S., Ariafar, A., Makarem, A., Ahmed, F., & Askarpour, M. (2025). Survival and oncological outcomes for young men (≤ 55 years) undergoing radical prostatectomy for localized prostate cancer. Archivio Italiano Di Urologia E Andrologia. https://doi.org/10.4081/aiua.2025.12658
Copyright (c) 2025 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.